CTRI/2024/03/064586
Not yet recruiting
Phase 3
pfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cavity Squamous Cell Cancers With Advanced Nodal Disease (SurVIC Trial): A Phase 3 Multicentric Randomized Controlled Trial - SurVIC Trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: C069- Malignant neoplasm of mouth, unspecified
- Sponsor
- Indian Council of Medical Research
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Biopsy proven, operable oral Squamous cell carcinoma cT1\-T4; cN2\-N3, with adequate organ function, Age\- 18\-75 years, ECOG\-PS:0\-2
Exclusion Criteria
- •Pregnant, History of moderate to severe hearing loss, History of previous malignancy excluding non\-melanoma skin cancers or cervical carcinoma in situ, Documented Weight loss of more than 15% in the last 6 months, or Patients with known HIV, hepatitis B or C infection.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Cancer injection before surgery vs after surgery in stomach cancerHealth Condition 1: C16- Malignant neoplasm of stomachCTRI/2021/01/030183Jawaharlal Institute of Postgraduate Medical Education and Reserach
Active, not recruiting
Phase 1
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224
Completed
Phase 3
eo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases ;The CHARISMA randomized multicenter clinical trialLiver metastases colorectal cancer1001981510017998NL-OMON44796Erasmus MC, Universitair Medisch Centrum Rotterdam224
Not yet recruiting
Not Applicable
Chemotherapy followed by versus surgery alone in high-risk patients with colorectal liver metastasesColorectal liver metastases, clinical risk score, high risk patients, colorectale levermetastasen, klinische risico score, hoog risico patientenNL-OMON27498Prof. Dr. C. VerhoefErasmus MC Cancer Institute224
Not yet recruiting
Phase 3
Surgery first vs chemotherapy first in early triple negative and HER2 positive breast cancer.Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteCTRI/2024/02/063118Tata Memorial Centre